VOV.VN - A further 219 people, including 9 entrants to the country, tested positive for the SASR-CoV-2 virus on the evening of July 2, thereby lifting the daily infection count to 545, according to figures given by the Ministry of Health.

VOV.VN - A further 43 local COVID-19 cases and one imported infection were recorded on June 8 morning, with current hotspots of Bac Ninh, Bac Giang and Ho Chi Minh City taking the most, according to data released by the Health Ministry.

VOV.VN - Nanogen Pharmaceutical Biotechnology JSC have announced plans to launch the third phase of human trials for its locally-produced coronavirus vaccine Nano Covax on May 5, a timeframe which is three months ahead of schedule.

The first three months of the year have witnessed more local businesses beef up their mergers and acquisitions efforts in order to scale up operations.

VOV.VN - Locally-produced drugs are set to reach 75% of demand and 60% of market value in the country, with the proportion of using domestic herbal medicines increasing by at least 10% over the course of last year.

VOV.VN - A total of 367 volunteers, including 30 people over the age of 60, have been injected with Nano Covax, the nation’s first locally-produced novel coronavirus (COVID-19) vaccine as part of the second phase of human trials, according to the Military Medical University.

VOV.VN - The Ministry of Health confirmed no new locally-transmitted COVID-19 cases on the morning of March 1, keeping the national tally at 2,448, while the total recoveries hit 1,876 in total after a further 32 coronavirus patients were declared free from the virus one day earlier.

Social distancing and strict control at hospitals, and an economic recession due to COVID-19, resulted in lower sales of both prescription and non-prescription drugs. However, many companies still witnessed outstanding performance.

The pharmaceutical industry grew by just 2.8% last year, much lower than its average 11.8% growth in the last five years.

VOV.VN - The country will get approximately five million doses of the novel coronavirus (COVID-19) vaccine by the end of February, including some 4.9 million vaccine doses provided via Covax, a global mechanism for developing, manufacturing, and procuring the COVID-19 vaccine.